CD38 expression labels an activated subset within chronic lymphocytic leukemia clones enriched in proliferating B cells. - Wikidata - wikimedia - TriplyDB

CD38 expression labels an activated subset within chronic lymphocytic leukemia clones enriched in proliferating B cells.

CD38 expression labels an activated subset within chronic lymphocytic leukemia clones enriched in proliferating B cells.

http://www.wikidata.org/entity/Q36384860

about

Clinical and laboratory prognostic indicators in chronic lymphocytic leukemia The pathogenesis of chronic lymphocytic leukemia CD38/CD31 interactions activate genetic pathways leading to proliferation and migration in chronic lymphocytic leukemia cells Gene expression signatures of radiation response are specific, durable and accurate in mice and humans.Cellular origin(s) of chronic lymphocytic leukemia: cautionary notes and additional considerations and possibilities.The role of ATM mutations and 11q deletions in disease progression in chronic lymphocytic leukemia.The pathogenic relevance of the prognostic markers CD38 and CD49d in chronic lymphocytic leukemia Distinct homotypic B-cell receptor interactions shape the outcome of chronic lymphocytic leukaemia MicroRNA expression profiling identifies activated B cell status in chronic lymphocytic leukemia cells.Many chronic lymphocytic leukemia antibodies recognize apoptotic cells with exposed nonmuscle myosin heavy chain IIA: implications for patient outcome and cell of origin Large-scale analysis of DNA methylation in chronic lymphocytic leukemia Differential bone marrow homing capacity of VLA-4 and CD38 high expressing chronic lymphocytic leukemia cells.Relevance of stereotyped B-cell receptors in the context of the molecular, cytogenetic and clinical features of chronic lymphocytic leukemia.In vivo intraclonal and interclonal kinetic heterogeneity in B-cell chronic lymphocytic leukemia.The MEC1 and MEC2 lines represent two CLL subclones in different stages of progression towards prolymphocytic leukemia.Prognostic factors identified three risk groups in the LRF CLL4 trial, independent of treatment allocation Programmed death-1 and its ligand are novel immunotolerant molecules expressed on leukemic B cells in chronic lymphocytic leukemia Dipeptidyl peptidase 2 apoptosis assay determines the B-cell activation stage and predicts prognosis in chronic lymphocytic leukemia The genomic landscape of chronic lymphocytic leukemia: clinical implications.Role of CTLA4 in the proliferation and survival of chronic lymphocytic leukemia.The B lineage transcription factor E2A regulates apoptosis in chronic lymphocytic leukemia (CLL) cells.Higher gene expression variability in the more aggressive subtype of chronic lymphocytic leukemia.A novel adoptive transfer model of chronic lymphocytic leukemia suggests a key role for T lymphocytes in the disease.Immunophenotypic and gene expression analysis of monoclonal B-cell lymphocytosis shows biologic characteristics associated with good prognosis CLL.CD69 is independently prognostic in chronic lymphocytic leukemia: a comprehensive clinical and biological profiling study.Co-culture of primary CLL cells with bone marrow mesenchymal cells, CD40 ligand and CpG ODN promotes proliferation of chemoresistant CLL cells phenotypically comparable to those proliferating in vivo State-of-the-Art Management of Patients Suffering from Chronic Lymphocytic Leukemia.TLR-9 and IL-15 Synergy Promotes the In Vitro Clonal Expansion of Chronic Lymphocytic Leukemia B Cells.Torque teno virus 10 isolated by genome amplification techniques from a patient with concomitant chronic lymphocytic leukemia and polycythemia vera.Stromal endothelial cells establish a bidirectional crosstalk with chronic lymphocytic leukemia cells through the TNF-related factors BAFF, APRIL, and CD40L.Vincristine activates c-Jun N-terminal kinase in chronic lymphocytic leukaemia in vivo T-cell independent, B-cell receptor-mediated induction of telomerase activity differs among IGHV mutation-based subgroups of chronic lymphocytic leukemia patients.Targeting neddylation induces DNA damage and checkpoint activation and sensitizes chronic lymphocytic leukemia B cells to alkylating agents Perifosine as a potential novel anti-telomerase therapy.Inter- and intra-patient clonal and subclonal heterogeneity of chronic lymphocytic leukaemia: evidences from circulating and lymph nodal compartments.CD38 and chronic lymphocytic leukemia: a decade later.Biology of chronic lymphocytic leukemia in different microenvironments: clinical and therapeutic implications.Chronic lymphocytic leukemia/small lymphocytic lymphoma with cyclin D1 positive proliferation centers do not have CCND1 translocations or gains and lack SOX11 expression.Adoptive T-cell immunotherapy of chronic lymphocytic leukaemia.c-Cbl tyrosine kinase-binding domain mutant G306E abolishes the interaction of c-Cbl with CD38 and fails to promote retinoic acid-induced cell differentiation and G0 arrest

P2860

Q26830323-3AC2351E-5FCF-4893-8312-63979E396A28 Q27025715-694639C1-B7EB-4B0C-8812-9154F85DF7A3 Q30484805-A32CF2D1-5C78-4C4E-9E9D-F565F24C6B5D Q33326641-6E9F448F-0930-4969-B5BD-E842455F62D7 Q33350258-529DCF94-E322-4414-B871-1F0EA815640D Q33409459-57630446-B6C9-4AD6-A24D-0022F98FE438 Q33655756-DDBE72D4-067A-48B2-97F7-72EB78475CC9 Q33804706-1C9AB71E-DB02-4ACA-8B5A-83818FD91CC7 Q33847322-B6F3D6A9-8F59-4810-A120-F7E2DF074506 Q33849548-4A4876AD-D6C6-4980-AB38-3652C05E41CA Q33859881-9BE0B13B-80BF-439C-924B-8D2E471C8661 Q34005556-7171DACF-73A2-44F6-9119-32C4E6365D36 Q34012864-E4FA2F7E-A439-4F7C-AD73-619947414F46 Q34078726-E9EFC572-CECD-4D05-A592-8CCB1D325904 Q34097631-D63982C0-D88E-4238-9D65-7A9AAC1937F1 Q34166551-CE79515C-10FE-461E-B592-6512E4A6030B Q34245048-2A40AD18-0917-4A50-BE4D-15690D409575 Q34349298-497DA7E9-2299-421A-9F54-CFB838F8C502 Q34710882-AE68F0F1-A7AF-4C01-8F82-6A9D09F836DF Q34925487-71FD1A5A-EC2E-4F43-9221-D1A95C1E1AE5 Q35011166-802CD07C-E265-47EE-B34E-9D76E87A618B Q35021249-4C59000E-CF5D-49AC-8117-2CD59D82D96C Q35029969-FA6E1069-6F30-4F98-91D2-CAE860B1DEAA Q35188629-DA225DC9-C797-48E5-B2E3-392B0CF5FCEF Q35717883-8F48B101-1041-4FA2-9AD6-5051377BDB81 Q35781372-C8200A5E-8EED-4D47-AB0E-8D5A805752FE Q35860550-0EBD5099-B2F7-4424-A5C2-BCFD76083645 Q35861964-C0A590BA-AB5F-469C-A27C-70D631CB412D Q35876861-356877E4-E3BA-4421-9FAA-57609D22B62F Q36016378-58D53BB1-77E8-4386-8717-7FE3ACDE8AE8 Q36072490-15C51F90-9817-40AC-8463-B0DCE1555A21 Q36250927-15F26D47-DD8F-496F-9454-434743A9BBAC Q36293814-98014868-FDA5-4E7A-8BE8-B5F41652B7B7 Q36355806-32843E2B-5537-4B3A-AB9B-599C38E6F7BD Q36520447-41902993-F317-415D-8CC9-6AD1F77230B9 Q36615126-74861A3C-E235-48E7-848B-599B6F074442 Q36862781-575926A5-6CF6-4EB5-ACE8-50ECCEBE68C5 Q36979738-75A4DDCD-7255-4128-BA89-0C59BF5804DD Q37268297-CCF9F108-7A04-40A1-95FA-B2E545E45A5F Q37377645-CA3AFB8B-3F7D-4723-8570-E13BD65FC27B

P2860

CD38 expression labels an activated subset within chronic lymphocytic leukemia clones enriched in proliferating B cells.

http://www.wikidata.org/entity/Q36384860

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh

2007年學術文章

@zh-hant

name

CD38 expression labels an acti ...... ched in proliferating B cells.

@ast

CD38 expression labels an acti ...... ched in proliferating B cells.

@en

type

label

CD38 expression labels an acti ...... ched in proliferating B cells.

@ast

CD38 expression labels an acti ...... ched in proliferating B cells.

@en

prefLabel

CD38 expression labels an acti ...... ched in proliferating B cells.

@ast

CD38 expression labels an acti ...... ched in proliferating B cells.

@en

P1433

Q36384860-C835D988-8726-45C7-A983-8419C5E54E2C

P1476

Q36384860-E4F4CD52-DD07-4F2B-A9A7-BEC506AE0B13

P2093

Q36384860-1C16215F-3B27-4CD5-96C4-72C0F307BD37

Q36384860-1EFC24D2-A393-47F6-8278-7D0EB86B5AFB

Q36384860-4B337D73-1960-4828-AECF-DDE07AA4A4DF

Q36384860-6AEF136B-3FF5-45D4-AEC9-20E40BFC3AD7

Q36384860-9CA244F3-9762-4C35-B6EF-9A144395C96A

Q36384860-B10CCE45-D735-4679-A3E1-6857AF1BC506

Q36384860-DC999AD3-2B7A-49A3-8EFA-ED69FA32A6CD

Q36384860-E3CC8646-E06F-42C4-A674-0982208F01DC

Q36384860-E4CF7103-FD50-48C6-91A1-87BE06CCF7D6

P2860

Q36384860-0490EB8A-E063-42FC-B03D-DB2521A3BC9A

Q36384860-06269FC4-114C-45EA-9EBB-53B2DD91E253

Q36384860-0E87FC03-0951-4660-B5BA-B009E5A36A87

Q36384860-1486D243-6E06-4BC5-BB23-2F64ECE8D1E2

Q36384860-14F6A23D-B926-4995-893B-3CC6BCA3D762

Q36384860-222000F6-2681-44A6-903C-08015838DC9F

Q36384860-24EE9775-0AD0-4D0C-8101-BCCE4B4BAA83

Q36384860-287726D2-4B82-400C-A656-C0D6C0220F52

Q36384860-2E7D52B5-0ABE-4E28-AEAD-BDF895C15A97

Q36384860-37208015-775B-44DF-9A11-2ACC9935F3F7

P304

Q36384860-1CB2C735-49C7-44A0-9FC5-94083476B976

P31

Q36384860-23B7368E-75DD-4AA9-923A-3D018390624B

P356

Q36384860-6F22E355-B9A9-4A73-AE32-D2FB06670833

P407

Q36384860-38DDF57C-47DA-4C3A-B9D6-A18F11B293E6

P433

Q36384860-80C79E53-5323-4409-8953-3F551807C8BB

P478

Q36384860-017C21D4-5E30-4EE9-8C02-5F10B8CD047D

P577

Q36384860-9D0240EC-270B-4208-80B0-24726C59C981

P5875

Q36384860-B0FCF7D1-1674-478B-92EB-BD8D916E25DE

P698

Q36384860-BFD7451C-3D94-4300-A6BA-E5BC2B4B6C72

P921

Q36384860-E3944285-3D9C-4DA9-8522-614C54D09928

Q36384860-F31C22CE-8667-48AC-9C42-FB021F3F9EFD

P932

Q36384860-85B2C9E0-9268-4376-941D-FF39518495E1

P356

BLOOD-2007-04-083832

P1433

P1476

CD38 expression labels an acti ...... ched in proliferating B cells.

@en

P2093

Carlo Calissano

http://www.w3.org/2001/XMLSchema#string

Cristina Sison

http://www.w3.org/2001/XMLSchema#string

Kanti R Rai

http://www.w3.org/2001/XMLSchema#string

Nicholas Chiorazzi

http://www.w3.org/2001/XMLSchema#string

Rajendra N Damle

http://www.w3.org/2001/XMLSchema#string

Sonal Temburni

http://www.w3.org/2001/XMLSchema#string

Sophia Yancopoulos

http://www.w3.org/2001/XMLSchema#string

Steven L Allen

http://www.w3.org/2001/XMLSchema#string

Taraneh Banapour

http://www.w3.org/2001/XMLSchema#string

P2860

CD38 and CD100 lead a network of surface receptors relaying positive signals for B-CLL growth and survival

Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia

Specific association of human telomerase activity with immortal cells and cancer

Genomic aberrations and survival in chronic lymphocytic leukemia

The Ki-67 protein: from the known and the unknown

Chronic lymphocytic leukemia

Human CD38 (ADP-ribosyl cyclase) is a counter-receptor of CD31, an Ig superfamily member

Identification of a human peripheral lymph node homing receptor: a rapidly down-regulated adhesion molecule

In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells

Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia.

P304

3352-3359

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2007-04-083832

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

110

http://www.w3.org/2001/XMLSchema#string

P577

2007-08-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6155687

http://www.w3.org/2001/XMLSchema#string

P698

17684154

http://www.w3.org/2001/XMLSchema#string

P921

P932

2200908

http://www.w3.org/2001/XMLSchema#string